First National Advisers’s Quest Diagnostics DGX Stock Holding History

First National Advisers’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.93M	Sell	9,091 -4,550	-33%	-$893K	0.27%	93
2026 Q1	$2.67M	Sell	13,641 -187	-1%	-$36.3K	0.39%	71
2025 Q4	$2.4M	Buy	13,828 +1,482	+12%	+$270K	0.33%	83
2025 Q3	$2.35M	Buy	12,346 +3,366	+37%	+$597K	0.32%	93
2025 Q2	$1.61M	Buy	+8,980	New	+$1.56M	0.24%	115

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

First National Advisers's DGX Position: Q2 2026 in Review

First National Advisers reduced its Quest Diagnostics (DGX) stake by 33% in Q2 2026, selling an estimated $893K and leaving 9,091 shares worth $1.93M. The position accounts for 0.27% of the portfolio, ranked #93.

First National Advisers first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.67M in Q1 2026. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

First National Advisers held 9,091 shares of Quest Diagnostics worth $1.93M as of Q2 2026.
First National Advisers sold 4,550 Quest Diagnostics shares in Q2 2026, an estimated $893K.
Quest Diagnostics made up 0.27% of First National Advisers's portfolio in Q2 2026, its #93 holding.
First National Advisers first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
First National Advisers's Quest Diagnostics position peaked at $2.67M in Q1 2026.
1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on First National Advisers's 13F filing for Q2 2026, filed 21 Jul 2026.